Table 3.
Bacterial Isolates | Antimicrobial Agents/Number of Isolates (%) | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gram Negative | N | S, R | AMP | TET | SXT | GEN | CXM | CTX | AMK | CIP | LEV | CAZ | MEM | TZP | AMC | FEP | CL |
E. coli | 24 | S | 22 (92) | 23 (96) | 24 (100) | 15 63) | 21 88) | 22 (92) | 6 (25) | 21 (88) | 22 (92) | 20 (83) | 21 (88) | 7 (29) | 19 (79) | 5 (21) | - |
R | 2 (8) | 1 (4) | 0 (0) | 9 (37) | 3 (12) | 2 (8) | 18 (75) | 3 (12) | 2 (8) | 4 (17) | 3 (12) | 17 (71) | 5 (21) | 19 (79) | - | ||
P. aeruginosa | 19 | S | - | - | - | 7 (37) | - | - | 5 (26) | 13 (16) | 12 (63) | 4 (21) | 15 (79) | 5 (26) | - | 3 (16) | 3 (16) |
R | - | - | - | 12 (63) | - | - | 14 (74) | 16 (84) | 7 (37) | 15 (79) | 4 (21) | 14 (74) | - | 16 (84) | 16 (84) | ||
Gram positive | AMP | TET | SXT | GEN | CXM | LEV | TZP | AMC | FEP | ERY | VA | FOX | CC | TEC | CL | ||
S. aureus | 12 | S R |
11 (92) | 10 (83) | 6 (50) | 4 (33) | 4 (33) | 7 (58) | 4 (33) | 2 (17) | 3 (25) | - | 9 (75) | - | 4 (33) | 5 (42) | - |
1 (8) | 2 (17) | 6 (50) | 8 (67) | 8 (67) | 5 (42) | 8 (67) | 10 (83) | 9 (75) | - | 3 (25) | - | 8 (67) | 7 (58) | - | |||
CoNS | 2 | S R |
2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 2 (100) | 0 (0) | 2 (100) | 2 (100) | 1 (50) | 0 (0) | 2 (100) | 2 (100) |
0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 0 (0) | 2 (100) | 0 (0) | 0 (0) | 1 (50) | 2 (100) | 0 (0) | 0 (0) |
CoNS = coagulase-negative Staphylococci; S = Sensitive; R = Resistant; - = Antibiotic not tested; AMP = Ampicillin; Tet = Tetracycline; SXT = Trimethroprim/sulfamethoxazole; Gen = Gentamycin; CXM = Cefuroxime; CTX = Cefotaxime; AMK = Amikacin; CIP = Ciprofloxacin; LEV = Levofloxacin; CAZ = Ceftazidime; MEM = Meropenem; TZP = Piperacillin/Tazobactam; AMC = Amoxicillin/Clavulanic acid; FEP = Cefepime; CL = Colistin; ERY = Erythromycin, FOX = Cefoxitin, VA = Lancomycin, TEC = Teicoplanin and CC = Clindamycin.